These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11194604)

  • 1. Prevention of recurrent ventricular fibrillation by ventricular rate stabilization.
    Grimm W; Hoffmann J; Menz V; Maisch B
    Europace; 2000 Oct; 2(4):346-9. PubMed ID: 11194604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Out of the guidelines: should an intracardiac defibrillator be implanted in patients with recurrent early ventricular fibrillation due to recurrent acute myocardial infarction?
    Faggiano P; Pulcini E; Curnis A; Vizzardi E; Cas LD
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):371-3. PubMed ID: 17443105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A; Ghidina M
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract]   [Full Text] [Related]  

  • 4. Recurrent ventricular fibrillation caused by coronary artery spasm leading to implantable cardioverter defibrillator implantation.
    Hendriks ML; Allaart CP; Bronzwaer JG; Res JJ; de Cock CC
    Europace; 2008 Dec; 10(12):1456-7. PubMed ID: 18978363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment.
    Mizusawa Y; Sakurada H; Nishizaki M; Hiraoka M
    J Cardiovasc Pharmacol; 2006 Mar; 47(3):359-64. PubMed ID: 16633076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular fibrillation initiated by an electrocution injury and terminated by an implantable cardioverter-defibrillator.
    Perret JN; Sanders TW; d'Autremont SB; Patrick HC
    J La State Med Soc; 2009; 161(6):343-7. PubMed ID: 20108829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-terminated ventricular fibrillation and recurrent syncope.
    Konstantino Y; Morello A; Zimetbaum PJ; Josephson ME
    Am J Cardiol; 2011 Feb; 107(4):638-40. PubMed ID: 21295177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Repeated early systemic lysis in acute myocardial infarct with recurrent ventricular fibrillation].
    Bodemann T; Nunberger D; Hochrein H
    Dtsch Med Wochenschr; 1988 Mar; 113(12):467-9. PubMed ID: 3349947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying the new STEMI guidelines: 2. Disturbances of cardiac rhythm after ST-segment elevation myocardial infarction.
    Dorian P; Bogaty P; Buller CE; O'Neill BJ; Armstrong PW;
    CMAJ; 2004 Oct; 171(9):1042-4. PubMed ID: 15505263
    [No Abstract]   [Full Text] [Related]  

  • 12. Short-long-short sequence caused by ventricular safety pacing inducing ventricular tachycardia in a patient with a dual-chamber implantable cardioverter defibrillator.
    Hayashi M; Takatsuki S; Messali A; Milliez P; Extramiana F; Leenhardt A
    Europace; 2008 Oct; 10(10):1238-42. PubMed ID: 18617506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automatic implantable cardioverter defibrillator for the treatment of ventricular fibrillation following coronary artery spasm: a case report.
    Al-Sayegh A; Shukkur AM; Akbar M
    Angiology; 2007; 58(1):122-5. PubMed ID: 17351169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The implantable cardioverter-defibrillator: sometimes necessary].
    Smeets JL
    Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2113-5. PubMed ID: 15553353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings.
    Della Bella P; De Ponti R; Uriarte JA; Tondo C; Klersy C; Carbucicchio C; Storti C; Riva S; Longobardi M
    Eur Heart J; 2002 Mar; 23(5):414-24. PubMed ID: 11846499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent ventricular arrhythmia after coronary artery bypass grafting treated with radiofrequency catheter ablation.
    Atik FA; Garcia MF; Baggio JM; Faber CN; Corso RB; Caneo LF; Sarabanda AV
    Ann Thorac Surg; 2009 Feb; 87(2):631-3. PubMed ID: 19161802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upper limit of vulnerability determination during implantable cardioverter-defibrillator placement to minimize ventricular fibrillation inductions.
    Glikson M; Gurevitz OT; Trusty JM; Sharma V; Luria DM; Eldar M; Shen WK; Rea RF; Hammill SC; Friedman PA
    Am J Cardiol; 2004 Dec; 94(11):1445-9. PubMed ID: 15566924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biventicular pacing in patients with severe heart failure].
    Merkely B; Vágó H; Bartha E; Zima E; Moravcsik E; Gellér L
    Orv Hetil; 2001 Dec; 142(51):2835-40. PubMed ID: 11828932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
    Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
    Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients.
    Wichter T; Paul M; Wollmann C; Acil T; Gerdes P; Ashraf O; Tjan TD; Soeparwata R; Block M; Borggrefe M; Scheld HH; Breithardt G; Böcker D
    Circulation; 2004 Mar; 109(12):1503-8. PubMed ID: 15007002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.